UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034702
Receipt number R000039560
Scientific Title Long-term outcomes of endovascular treatment for peripheral artery disease in Kumamoto multicenter registry
Date of disclosure of the study information 2018/10/30
Last modified on 2019/04/15 20:47:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long-term outcomes of endovascular treatment for peripheral artery disease in Kumamoto multicenter registry

Acronym

Kumamoto EVT registry

Scientific Title

Long-term outcomes of endovascular treatment for peripheral artery disease in Kumamoto multicenter registry

Scientific Title:Acronym

Kumamoto EVT registry

Region

Japan


Condition

Condition

peripheral artery disease

Classification by specialty

Cardiology Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We accumulate present data of endovascular treatment for peripheral arterial disease and compare the results between conventional therapeutic devices and novel ones. We also assess the difficulty of treatment by lesion properties and the risk of restenosis in multicenter. We assess and clarify the future therapeutic problems.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. Target Vessel Revascularization:TVR
2. Improvement of maximun walk distance

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Symptomatic lower peripheral artery disease patients more than 20 years old who undergo endovascular treatment (EVT).

Key exclusion criteria

1) No consent for this study.
2) Scheduled bypass grafting or lower leg amputation.
3) Patients less than 20 years old.
4) Life expectancy less than 1 year.
5) Acute limb ischemia.
6) Patients who have the difficulty for use of contrast media due to allergy or severe renal dysfunction.
7) Patients who have the difficulty for anti-thrombotic therapy.
8) Patients who take part in the other study.
9) In case the chief researcher decides the enrolled patients is inappropriate for this study.
10) EVT for deep femoral artery only
11) Rutherford 6

Target sample size

1500


Research contact person

Name of lead principal investigator

1st name Kenichi
Middle name
Last name Tsujita

Organization

Kumamoto University

Division name

Department of Cardiovascular Medicine Graduate School of Medical Sciences

Zip code

8608556

Address

1-1-1 Honjo, Chuo-ku, Kumamoto City, Japan

TEL

81-96-373-5175

Email

tsujita@kumamoto-u.ac.jp


Public contact

Name of contact person

1st name Koichiro
Middle name
Last name Fujisue

Organization

Kumamoto University

Division name

Department of Cardiovascular Medicine Graduate School of Medical Sciences

Zip code

8608556

Address

1-1-1 Honjo, Chuo-ku, Kumamoto City, Japan

TEL

81-96-373-5175

Homepage URL


Email

fujisues@kumamoto-u.ac.jp


Sponsor or person

Institute

Kumamoto University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the Human Ethics Review Committee of Kumamoto University Graduate School of Medicine

Address

1-1-1 Honjo, Chuo-ku, Kumamoto City, Japan

Tel

81-96-373-5657

Email

byi-senshin@jimu.kumamoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 10 Month 18 Day

Date of IRB

2017 Year 10 Month 18 Day

Anticipated trial start date

2017 Year 10 Month 18 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

observational study


Management information

Registered date

2018 Year 10 Month 30 Day

Last modified on

2019 Year 04 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039560


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name